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Abstract
Background: Severe accidental hypothermia is defined as a core temperature below 28 Celsius degrees. Within the last 
years, the issue of accidental hypothermia and accompanying cardiac arrest has been broadly discussed and European 
Resuscitation Council (ERC) Guidelines underline the importance of Extracorporeal Rewarming (ECR) in treatment of 
severely hypothermic victims. The study aimed to evaluate the actual costs of ECR with VA-ECMO and of further manage-
ment in the Intensive Care Unit of patients admitted to the Severe Accidental Hypothermia Centre in Cracow, Poland.
Methods: We carried out the economic analysis of 31 hypothermic adults in stage III-IV (Swiss Staging) treated with 
VA ECMO. Twenty-nine individuals were further managed in the Intensive Care Unit. The actual treatment costs were 
evaluated based on current medication, equipment, and dressing pricing. The costs incurred by the John Paul II Hos-
pital were then collated with the National Health Service (NHS) funding, assessed based on current financial contract.
Results: In most of the cases, the actual treatment cost was greater than the funding received by around 10000 PLN per 
patient. The positive financial balance was achieved in only 4 (14%) individuals; other 25 cases (86%) showed a financial loss.
Conclusion: Performed analysis clearly shows that hospitals undertaking ECR may experience financial loss due to imple-
mentation of effective treatment recommended by international guidelines. Thanks to new NHS funding policy since January 
2017 such loss can be avoided, what shall encourage hospitals to perform this expensive, yet effective method of treatment.
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Hypothermia is defined as a core body temperature (Tc) 
below 35°C [1]. According to data from the Central Statisti-
cal Office, between 2009 and 2012, exposure to excessive 
natural cold was the initial cause of death of 1,835 people, 
489 (27%) of whom died in hospitals [2]. A questionnaire 
study carried out in 50 emergency departments that provide 
care for a population of over 4 million individuals revealed 
that the incidence of accidental hypothermia was 6 cases 
per 100,000 annually [3]. 
In several recent years, the issue of therapy for patients 
with severe stages of hypothermia, including cardiac arrest 
(stages III and IV according to the Swiss Staging System), has 
increasingly been disputed in the international literature. In 
the European Resuscitation Council guidelines, a Tc below 
28°C accompanied by haemodynamic instability or cardiac 
arrest during hypothermia was considered an indication for 
extracorporeal rewarming (ECR) [4].
The success of medical management depends on the 
proper identification of patients, the administration of ap-
propriate treatments, the coordination of actions at various 
levels of care and the availability of effective targeted thera-
pies [5]. Based on the opinions of experts and the guidelines 
of the European Resuscitation Council, pre-hospital and 
hospital protocols for the management of patients with hy-
pothermia were created [1, 4, 6]. The protocols enabled the 
comprehensive and organised use of advanced treatment 
methods for victims of severe hypothermia, including the 
initiation of ECR by a mobile team equipped with a portable 
extracorporeal membrane oxygenation (ECMO) system.
In an effort to meet the challenge of treating severely 
hypothermic patients, the Severe Accidental Hypothermia 
Centre (SAHC) was created within the Department of An-
aesthesiology and Intensive Care at John Paul II Hospital in 
Cracow. The Centre treats patients in the same setting ac-
cording to the same algorithm and by the same team, which 
provides a unique opportunity to estimate the costs of 
therapy (which have never been assessed before, according 
to some authors) and to analyse its cost effectiveness. The 
data obtained may be relevant for other centres interested 
in the implementation of ECR for hypothermic patients. 
Methods
The study’s goal was to perform a financial analysis 
of venous-arterial extracorporeal membrane oxygenation 
(VA-ECMO) and to determine the general costs of therapy 
for patients with severe accidental hypothermia receiving 
intensive care at the Department of Anaesthesiology and 
Intensive Care in Cracow. The medical records of patients 
admitted to the Severe Accidental Hypothermia Centre 
between November 2013 and September 2016 were ana-
lysed. The study included 31 adult patients undergoing 
extracorporeal rewarming whose Tcs ranged from 15.2°C to 
29°C. The analysis involved the costs of the implementation 
of VA-ECMO and of patients’ stays, including laboratory and 
microbiological tests, imaging examinations and transfu-
sions of blood and blood-derived products. The costs were 
assessed based on the actual pricing of drugs, equipment 
and dressing materials purchased by the hospital. The hos-
pital income resulted from funding from the National Health 
Fund (NFZ), which provided compensation for services clas-
sified as medical procedures. 
Results
The study group included 17 patients rewarmed during 
cardiac arrest and 14 patients with cardiogenic shock. The 
time between cardiac arrest and the initiation of extracor-
poreal therapy ranged from 107 to 345 minutes. In 2 pa-
tients, management was provided by the mobile ECR team. 
In the cases of 29 (94%) of the patients, the VA-ECMO 
system was implanted in the operating suite in the Depart-
ment of Cardiology and the treatment continued in the 
Intensive Care Unit (ICU). Two patients died before admis-
sion to the ICU — one in the operating suite and one in the 
Emergency Department at the district hospital. The mean 
length of stay in the intensive care unit in the Department 
of Anaesthesiology and Intensive Care was 9 days.
In the group with sudden cardiac arrest (SCA), ben-
efits from the treatment, such as stabilisation of the central 
temperature and the circulatory and respiratory systems, 
as well as recovery of consciousness and restitution of the 
baseline neurological condition, were observed in 8 out of 
17 patients (46%). Nine out of 17 patients died (53%). In the 
group with cardiogenic shock, beneficial effects from the 
therapy were noted in 8 out of 14 patients (57%); 6 patients 
in that group (43%) died. 
The cumulative analysis of costs is presented in Table 1. 
The incurred costs in the entire study group were —189 
314.99 PLN. The cost of extracorporeal rewarming for 
each patient exceeded the NHF refund by approximately 
10,000.00 PLN. A positive financial balance was achieved 
in only 4 out of 29 patients who qualified for this therapy 
(14%). Financial losses were noted for the remaining 25 
patients (86%). 
discussion
The collation of costs with incomes revealed financial 
losses incurred by the service provider for the majority of 
patients due to the implementation of effective therapy 
recommended by the international guidelines and the as-
sembly of experts. 
Funding for the protocol of management elaborated 
and implemented in the Severe Accidental Hypothermia 
Centre is based on cooperation with the Department of 
Anaesthesiology and Intensive Care and the Department 
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Tabela 1. Cumulative analysis of costs
Cardiac surgery
(PLN)
Intensive therapy
(PLN)
 Total cost 
of stay of 
30 patients 
including 
drugs and 
medical 
procedures 
(PLN)
 Total NHF 
refund
(PLN)
 Final
(PLN) 
 NHF  
refund 
 Costs of 
ECMO 
implantation  
and removal
 Balance  NHF refund  Costs  Balance
Sum total 648,232.00 541,263.31 106,968.69 674,331.32 970,615.00 –296,283.68 1,511,878.31 1,322,563.32 –189,314.99
Average  
per patient
21,607.73 18,042.11 3,565.62 22,477.71 32,353.83 –9,876.12 50,395.94 44,085.44 –6,310.50
of Cardiac Surgery. The main accounting procedure from 
the catalogue of services (group code E02 — other car-
diosurgical procedures) was listed by the Department of 
Cardiac Surgery, while the Department of Anaesthesiol-
ogy and Intensive Care accounted for the treatment of 
patients based on the TISSS-28. According to the biding 
regulations, procedure 5.51.01.0005002 could have been 
performedonly by cardiac surgery departments, and its 
valuation was 404 points. In searching for alternative fi-
nancing sources that would be adequate for the incurred 
costs, an attempt was made to consider ECMO therapy an 
obvious example of treatment for acute cardiopulmonary 
failure based on the recommendations of the National 
Supervisory Board and the National Consultant in Anaes-
thesiology and Intensive Therapy. In such cases, the major 
criterion for qualification is PaO2/FiO2 < 70 mm Hg at PEEP 
≥ 10 cm H2O that does not increase for at least 2 hours de-
spite optimal, conventional ventilation therapy [7]. The time 
condition cannot be fulfilled in severe hypothermia since 
extracorporeal rewarming has to be initiated as quickly 
as possible, and any modifications of the parameters can 
cause cardiac arrest. Likewise, the interpretation of PaO2/ 
/FiO2 in hypothermia is hindered due to cell metabolisms 
being critically reduced. Out of all of the patients treated, 
only one (who had concomitant aspiration pneumonia) 
fulfilled the required criteria. 
A positive financial balance following treatment at the 
Department of Anaesthesiology and Intensive Care, which av-
eraged 5,467.93 PLN, was achieved only for a small percentage 
of patients. Moreover, it should be stressed that in one case of 
a patient treated with ECMO by the mobile team in one of the 
district hospitals (Tc 15.2°C, cardiac arrest), the expenses were 
not refunded, resulting in the additional loss of 24,680 PLN. 
Several years of efforts in medical circles to ensure proper 
funding for extracorporeal rewarming in hypothermia resulted 
in the Directive of the Chairman of the National Health Fund 
No.129/2016/DSOZ on December 30, 2016. According to the 
Directive, the “ECMO — heart and lung support” procedure, 
which has a point value of 750, can be refunded in severe hypo-
thermia cases. Accordingly, the centres that gave gone to great 
lengths to perform extracorporeal therapy in hypothermia ul-
timately have grounds for refunding the costs of treatment un-
der novel, better conditions. Figure 1 presents the distribution 
of centres dedicated to ECMO therapy in severely hypother-
mic victims. The complete list of these centres is available at 
www.hipotermia.edu.pl. 
Thanks to numerous educational activities undertaken 
by the Severe Accidental Hypothermia Centre, the guide-
lines of National Consultants [8] and advances in knowledge 
about hypothermia in Polish medical circles, the personnel 
of first-choice centres for the treatment of severely hypo-
thermic patients will be able to register an increasingly 
high number of emergency notifications in the near future. 
Over a period of three years, the coordinators of the Severe 
Accidental Hypothermia Centre for Extracorporeal Therapy 
consulted 2005 hypothermic patients. 
The use of ECMO in severe hypothermia is a recognised 
life-saving procedure. This has been confirmed by studies 
Figure 1. Distribution of centres dedicated to ECMO therapy in 
severely hypothermic victims
Treatment of children
Treatment of adults
Treatment of adults and children
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from other countries as well as from our Centre [9–12]. How-
ever, an adequate model of funding and suitable adminis-
trative solutions are relevant factors affecting therapeutic 
decisions. We hope that the economic aspects of our Centre’s 
work and the options for extracorporeal rewarming funding 
presented above will dispel doubts and encourage other 
centres to implement this treatment method. 
conclusions 
1. The use of venous-arterial ECMO in patients with severe 
hypothermia can result in financial losses for service 
providers. 
2. The new funding policy introduced recently provides 
a basis for performing VA-ECMO without causing finan-
cial losses for service providers. 
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